Evidence map›Paper›PMID 41332180›Full record

ArticleTherapeutic advances in respiratory disease

Social risk factors in patients with cystic fibrosis: impacts on exacerbations, lung function, and BMI.

Zhuoyi Galvin Li, Deirdre Jennings, Lindsay Somerville, Sriyaa Suresh, Rhonda List, Kevin Lonabaugh, Margaret Mercante, Kasey Wilburn, Alexis Wiggins, Aaron Smith and 2 more

Abstract read
In one paragraph

Article in Therapeutic advances in respiratory disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Zhuoyi Galvin LiUniversity of Tennessee Health Science Center College of Medicine, 920 Madison Ave., Memphis, TN 38163, USA.ORCID 0009-0009-2528-2968
Deirdre JenningsDepartment of Medicine, University of Virginia, Charlottesville, VA, USA.
Lindsay SomervilleDepartment of Medicine, University of Virginia, Charlottesville, VA, USA.ORCID 0000-0001-7052-0640
Sriyaa SureshUniversity of Virginia School of Medicine, Charlottesville, VA, USA.
Rhonda ListDepartment of Medicine, University of Virginia, Charlottesville, VA, USA.
Kevin LonabaughDepartment of Medicine, University of Virginia, Charlottesville, VA, USA.
Margaret MercanteUniversity of Virginia School of Medicine, Charlottesville, VA, USA.
Kasey WilburnDepartment of Medicine, University of Virginia, Charlottesville, VA, USA.
Alexis WigginsUniversity of Virginia School of Medicine, Charlottesville, VA, USA.
Aaron SmithUniversity of Virginia School of Medicine, Charlottesville, VA, USA.
Andrew BarrosDepartment of Medicine, University of Virginia, Charlottesville, VA, USA.
Dana P AlbonDepartment of Medicine, University of Virginia, Charlottesville, VA, USA.ORCID 0000-0001-9055-3247

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCystic fibrosis (CF) outcomes are influenced by a myriad of genetic, microbiological, and environmental factors, as well as socioeconomic constraints. Studies have shown that low socioeconomic status is associated with a higher risk of death, lower body weight and height, worsened pulmonary function, and increased pulmonary exacerbation in children with CF. Screening for social risk factors (SRFs) is one possible approach to help mitigate unmet social needs in people with CF (PwCF).

objectivesDoes a positive screening response for SRF correlate with health outcomes in PwCF?

designThis is a single-center, retrospective analysis of outcomes in adult PwCF. The study includes data from 2021 to 2022.

methodsA social needs screening tool was administered to identify SRF in PwCF in eight domains: housing, food, transportation, utilities, healthcare cost, medication cost, income/employment, and education. A total of 121 PwCF were included in the analysis. Linear mixed-effects models, Poisson regression, and mixed-effects Cox regression were used for analyses of multivariate models.

resultsWhen adjusted for multiple covariables, PwCF who screened positive for SRF had similar lung function and BMI as PwCF who reported no SRF and an increased CF exacerbation rates per person/per year when compared to their peers, 1.700 (1.275, 2.266) versus 0.829 (0.608, 1.130) (

conclusionPwCF who responded positively for SRF experienced an increased rate of CF exacerbation, and this finding remained significant when adjusted for multiple variables, including new CF medications. Medication cost, income/employment concerns, and food insecurity emerged as the most significant predictors of exacerbation rates and time to the next exacerbation. Further studies are needed to evaluate effective interventions and resources to mitigate SRF.

Indexed as

Body Mass IndexCystic FibrosisLungSocial Determinants of HealthAdolescentAdultDisease ProgressionFemaleHumansMaleRespiratory Function TestsRetrospective StudiesRisk FactorsSocioeconomic FactorsYoung Adultcystic fibrosishealth disparitiespulmonary exacerbationssocial determinants of healthsocial risk factors

Identifiers

PMID41332180
PMCPMC12678736

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.